Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism MT-ND1 gene transference(mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 gene transference) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 26 May 2023 | |
Brain Diseases | Preclinical | JP | 30 Jul 2013 |